A nasal vaccine with inactivated whole-virion elicits protective mucosal immunity against SARS-CoV-2 in mice

INTRODUCTION: Vaccinations are ideal for reducing the severity of clinical manifestations and secondary complications of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2); however, SARS-CoV-2 continues to cause morbidity and mortality worldwide. In contrast to parenteral vaccines such as...

Descripción completa

Detalles Bibliográficos
Autores principales: Tokunoh, Nagisa, Tamiya, Shigeyuki, Watanabe, Masato, Okamoto, Toru, Anindita, Jessica, Tanaka, Hiroki, Ono, Chikako, Hirai, Toshiro, Akita, Hidetaka, Matsuura, Yoshiharu, Yoshioka, Yasuo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10500122/
https://www.ncbi.nlm.nih.gov/pubmed/37720231
http://dx.doi.org/10.3389/fimmu.2023.1224634

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10500122/
https://www.ncbi.nlm.nih.gov/pubmed/37720231
http://dx.doi.org/10.3389/fimmu.2023.1224634

Ejemplares similares